These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7354792)

  • 21. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
    Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
    Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both sides of the hypercoagulable state.
    Bennett JS
    Hosp Pract (1995); 1997 Nov; 32(11):105-8, 111-2, 119-21. PubMed ID: 9385317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboembolic disease: underdiagnosed, undertreated, deadly.
    Olin JW
    Cleve Clin J Med; 1994; 61(2):97-9; quiz 161. PubMed ID: 8194185
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of thrombosis in the cancer patient.
    Andrea N; Ansell J
    J Support Oncol; 2003; 1(4):235-8, 240-2; discussion 239-40, 243-5. PubMed ID: 15334865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep vein thrombosis and anticoagulant therapy.
    Sullano MA; Ortiz EJ
    Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of deep vein thrombosis.
    Chong BH
    Aust Fam Physician; 2001 Mar; 30(3):235-40. PubMed ID: 11301761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
    Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement.
    Francis CW; Pellegrini VD; Leibert KM; Totterman S; Azodo MV; Harris CM; Cox C; Marder VJ
    Thromb Haemost; 1996 May; 75(5):706-11. PubMed ID: 8725709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodilution: importance and validity in the prevention of deep venous thrombosis].
    d'Alessandro A; Impagliatelli M
    Minerva Cardioangiol; 1987 May; 35(5):287-9. PubMed ID: 3627481
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
    O'Brien BJ; Anderson DR; Goeree R
    CMAJ; 1994 Apr; 150(7):1083-90. PubMed ID: 8137188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of venous thrombosis.
    Sharnoff JG
    Lancet; 1970 Mar; 1(7647):617. PubMed ID: 4190568
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of venous thromboembolic (VTE) disease--Part I: Prevention.
    Kayser SR
    Prog Cardiovasc Nurs; 1995; 10(4):31-6. PubMed ID: 8584548
    [No Abstract]   [Full Text] [Related]  

  • 33. Exploring the role of low-molecular-weight heparins in pregnancy.
    Greer IA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing DVT following total knee replacement: a review of recent clinical trials.
    Fitzgerald RH
    Orthopedics; 1995 Jul; 18 Suppl():10-1. PubMed ID: 7479418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
    Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
    Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Deep venous thrombosis prevention (author's transl)].
    Moser G
    Ther Umsch; 1980 Feb; 37(2):118-21. PubMed ID: 7385078
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ineffectiveness of preventive low-dose heparin administration in pacemaker implantation].
    Münch U; Mombelli G
    Schweiz Med Wochenschr; 1980 Jul; 110(30):1125-8. PubMed ID: 7423159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.